N(+)-glucuronidation of aliphatic tertiary amines, a general phenomenon in the metabolism of H1-antihistamines in humans
- PMID: 1686692
- DOI: 10.3109/00498259109043203
N(+)-glucuronidation of aliphatic tertiary amines, a general phenomenon in the metabolism of H1-antihistamines in humans
Abstract
1. Representative drugs of the various structural classes of H1 antihistamines were chosen for study. The drugs chosen (class name in parentheses) were chlorpheniramine maleate and pheniramine maleate (alkylamines), diphenhydramine hydrochloride and doxylamine succinate (ethanolamines), pyrilamine maleate and tripelennamine hydrochloride (ethylenediamines), promethazine hydrochloride (phenothiazine), cyclizine lactate (piperazine) and terfenadine (miscellaneous). In each case oral dose(s) were administered over no more than 6 h to two healthy volunteers and the total urine collected for 36 h. 2. Metabolites from urine were separated by h.p.l.c. and individually collected prior to mass spectrometric analysis in the fast atom bombardment mode. The structure of each metabolite identified as a quaternary ammonium-linked glucuronide metabolite was confirmed by direct comparison of its mass spectrum and chromatographic behaviour with that of a synthetic authentic compound. 3. For eight of the nine drugs studied, metabolism by the N(+)-glucuronidation pathway was observed in each of the volunteers. Terfenadine was the exception. 4. The amount of each N(+)-glucuronide in the urine was estimated by h.p.l.c. analysis. The mean proportion of dose excreted as the metabolite was 14.3%, 6.5% and 4.0% for cyclizine, tripelennamine and diphenhydramine, respectively. Promethazine was the only case where the N(+)-glucuronide accounted for less than 1.0% of the administered dose in both volunteers examined.
Similar articles
-
Variability of diphenhydramine N-glucuronidation in healthy subjects.Eur J Drug Metab Pharmacokinet. 1997 Apr-Jun;22(2):151-4. doi: 10.1007/BF03189799. Eur J Drug Metab Pharmacokinet. 1997. PMID: 9248784
-
N(+)-glucuronidation of aliphatic tertiary amines in human: antidepressant versus antipsychotic drugs.Xenobiotica. 1995 Mar;25(3):291-301. doi: 10.3109/00498259509061853. Xenobiotica. 1995. PMID: 7618355
-
N+-glucuronidation, a common pathway in human metabolism of drugs with a tertiary amine group.Drug Metab Dispos. 1998 Sep;26(9):830-7. Drug Metab Dispos. 1998. PMID: 9733660 Review.
-
GAS CHROMATOGRAPHY OF SOME ANTIHISTAMINES.J Pharm Sci. 1964 Aug;53:887-91. doi: 10.1002/jps.2600530808. J Pharm Sci. 1964. PMID: 14241799 No abstract available.
-
Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).Clin Pharmacokinet. 1985 Nov-Dec;10(6):477-97. doi: 10.2165/00003088-198510060-00002. Clin Pharmacokinet. 1985. PMID: 2866055 Review.
Cited by
-
Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. Clin Pharmacokinet. 2009. PMID: 19902987
-
Variability of diphenhydramine N-glucuronidation in healthy subjects.Eur J Drug Metab Pharmacokinet. 1997 Apr-Jun;22(2):151-4. doi: 10.1007/BF03189799. Eur J Drug Metab Pharmacokinet. 1997. PMID: 9248784
-
Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.Clin Pharmacokinet. 1997 Mar;32(3):210-58. doi: 10.2165/00003088-199732030-00004. Clin Pharmacokinet. 1997. PMID: 9084960 Review.
-
Data Mining FAERS to Analyze Molecular Targets of Drugs Highly Associated with Stevens-Johnson Syndrome.J Med Toxicol. 2015 Jun;11(2):265-73. doi: 10.1007/s13181-015-0472-1. J Med Toxicol. 2015. PMID: 25876064 Free PMC article.
-
The pyridazine heterocycle in molecular recognition and drug discovery.Med Chem Res. 2023 Mar 15:1-69. doi: 10.1007/s00044-023-03035-9. Online ahead of print. Med Chem Res. 2023. PMID: 37362319 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources